Evidence map›Paper›PMID 40396901›Full record

ArticleSleep2025

PRO: CBT-I for insomnia treatment can be delivered by a range of healthcare providers.

Colin A Espie, Michael A Grandner, Christopher L Drake

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Why we should still ACT in CBT-I.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Colin A EspieSir Jules Thorn Sleep & Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID 0000-0002-1294-8734
Michael A GrandnerSleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.ORCID 0000-0002-4626-754X
Christopher L DrakeThomas Roth Sleep Disorders and Research Center, Henry Ford Health + Michigan State University, Detroit, MI, USA.ORCID 0000-0002-5486-3587

Funding

Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) StudyR01MD011600 · NIMHD · UNIVERSITY OF ARIZONA · PI GRANDNER, MICHAEL A · 2018 to 2022
$4.1M
The Mind After Midnight: Mechanistic Examination of Nocturnal Wakefulness as aSuicide Risk FactorR01MH135978 · NIMH · UNIVERSITY OF ARIZONA · PI Fabian Fernandez, Michael A Grandner · 2025 to 2026
$1.5M
National Institute for Health and Care Research NIHR203316NIMHD NIH HHS R01 MD011600NIMH NIH HHS R01 MH135978
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40396901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.